Lee A. Denson

24.7k total citations · 1 hit paper
235 papers, 7.2k citations indexed

About

Lee A. Denson is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Lee A. Denson has authored 235 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Genetics, 64 papers in Surgery and 59 papers in Epidemiology. Recurrent topics in Lee A. Denson's work include Inflammatory Bowel Disease (96 papers), Microscopic Colitis (45 papers) and Adolescent and Pediatric Healthcare (41 papers). Lee A. Denson is often cited by papers focused on Inflammatory Bowel Disease (96 papers), Microscopic Colitis (45 papers) and Adolescent and Pediatric Healthcare (41 papers). Lee A. Denson collaborates with scholars based in United States, Israel and Canada. Lee A. Denson's co-authors include Kevin A. Hommel, Michael R. Konikoff, Robert N. Baldassano, Saul J. Karpen, Wendy N. Gray, Erin Bonkowski, Xiaonan Han, David J. Mangelsdorf, Matthew A. Held and Ingrid Jurickova and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Lee A. Denson

225 papers receiving 7.0k citations

Hit Papers

Microbiota-derived butyrate restricts tuft cell different... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee A. Denson United States 47 2.4k 1.8k 1.7k 1.4k 1.3k 235 7.2k
Richard B. Gearry New Zealand 52 4.5k 1.9× 2.5k 1.4× 3.2k 1.9× 1.2k 0.9× 588 0.5× 311 9.5k
Johanna C. Escher Netherlands 40 4.0k 1.7× 2.2k 1.2× 2.7k 1.6× 1.2k 0.9× 319 0.3× 164 6.9k
James O. Lindsay United Kingdom 47 5.4k 2.3× 2.4k 1.3× 3.8k 2.3× 1.3k 0.9× 644 0.5× 215 9.2k
Michael D. Kappelman United States 51 5.6k 2.4× 4.2k 2.3× 4.6k 2.7× 1.1k 0.8× 1.4k 1.1× 282 11.6k
Rupert W. Leong Australia 51 3.6k 1.5× 3.0k 1.6× 3.0k 1.8× 1.1k 0.8× 1.6k 1.3× 336 9.6k
Millie D. Long United States 45 4.6k 1.9× 2.3k 1.3× 3.8k 2.3× 918 0.7× 668 0.5× 271 8.1k
Richard J. Grand United States 54 4.6k 1.9× 3.3k 1.8× 2.5k 1.5× 905 0.7× 562 0.4× 224 10.1k
Sunanda V. Kane United States 55 6.5k 2.7× 3.7k 2.0× 4.6k 2.8× 2.6k 1.9× 748 0.6× 304 11.4k
Ikuko Kato United States 55 950 0.4× 3.3k 1.8× 816 0.5× 847 0.6× 2.2k 1.7× 196 9.9k
Richard K. Russell United Kingdom 42 5.2k 2.2× 2.7k 1.5× 3.3k 2.0× 1.3k 0.9× 247 0.2× 188 7.6k

Countries citing papers authored by Lee A. Denson

Since Specialization
Citations

This map shows the geographic impact of Lee A. Denson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee A. Denson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee A. Denson more than expected).

Fields of papers citing papers by Lee A. Denson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee A. Denson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee A. Denson. The network helps show where Lee A. Denson may publish in the future.

Co-authorship network of co-authors of Lee A. Denson

This figure shows the co-authorship network connecting the top 25 collaborators of Lee A. Denson. A scholar is included among the top collaborators of Lee A. Denson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee A. Denson. Lee A. Denson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hornung, Lindsey, Lee A. Denson, Amy S. Shah, et al.. (2025). Islet Autoantibodies and Their Association With β-Cell Function and Diabetes Measures in Children With Acute Recurrent and Chronic Pancreatitis. Diabetes Care. 48(6). 974–981. 1 indexed citations
2.
Yu, Yen‐Rei, et al.. (2024). ZINC RESTRICTION BY INTESTINAL E. COLI - PRODUCED YERSINIABACTIN ACTIVATES HIF-1α IN MACROPHAGES TO PROMOTE CD-ASSOCIATED FIBROSIS. Inflammatory Bowel Diseases. 30(Supplement_1). S62–S62. 1 indexed citations
3.
Tominaga, Kentaro, Daniel O. Kechele, J. Guillermo Sanchez, et al.. (2024). Deriving Human Intestinal Organoids with Functional Tissue-Resident Macrophages All From Pluripotent Stem Cells. Cellular and Molecular Gastroenterology and Hepatology. 19(4). 101444–101444. 4 indexed citations
4.
Khandelwal, Pooja, Yael Haberman, Anil G. Jegga, et al.. (2023). Transcriptome analysis in acute gastrointestinal graft-<i>versus</i> host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Haematologica. 108(7). 1803–1816. 1 indexed citations
5.
Geem, Duke, David M. Hercules, Suresh Venkateswaran, et al.. (2023). Progression of Pediatric Crohn’s Disease Is Associated With Anti–Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization. Clinical Gastroenterology and Hepatology. 22(2). 368–376.e4. 9 indexed citations
6.
Venkateswaran, Suresh, Hari K. Somineni, Varun Kilaru, et al.. (2022). Methylation quantitative trait loci are largely consistent across disease states in Crohn’s disease. G3 Genes Genomes Genetics. 12(4). 4 indexed citations
7.
Colman, Ruben J., Tomoyuki Mizuno, Keizo Fukushima, et al.. (2022). Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary Pharmacology & Therapeutics. 57(5). 524–539. 12 indexed citations
8.
Colman, Ruben J., Tomoyuki Mizuno, Jeffrey S. Hyams, et al.. (2021). Antibodies‐to‐infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn’s disease. Alimentary Pharmacology & Therapeutics. 55(5). 593–603. 23 indexed citations
9.
Short, Sarah P., Jennifer M. Pilat, Caitlyn W. Barrett, et al.. (2020). Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer. Gastroenterology. 160(5). 1694–1708.e3. 49 indexed citations
10.
Ungaro, Ryan C., Liangyuan Hu, Jiayi Ji, et al.. (2020). Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease. Alimentary Pharmacology & Therapeutics. 53(2). 281–290. 32 indexed citations
11.
Aschenbrenner, Dominik, Maria Quaranta, Soumya Banerjee, et al.. (2020). Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut. 70(6). 1023–1036. 68 indexed citations
12.
El‐Serag, Hashem B., Cynthia Peacock, Lee A. Denson, et al.. (2019). Recommendations for Successful Transition of Adolescents With Inflammatory Bowel Diseases to Adult Care. Clinical Gastroenterology and Hepatology. 18(2). 276–289.e2. 18 indexed citations
13.
Plevinsky, Jill M., James Peugh, Lee A. Denson, et al.. (2019). Longitudinal non‐adherence predicts treatment escalation in paediatric ulcerative colitis. Alimentary Pharmacology & Therapeutics. 50(8). 911–918. 9 indexed citations
14.
Dorn, Lorah D., Jochebed G. Gayles, Christopher G. Engeland, et al.. (2016). Cytokine Patterns in Healthy Adolescent Girls: Heterogeneity Captured by Variable and Person-Centered Statistical Strategies. Psychosomatic Medicine. 78(6). 646–656. 16 indexed citations
15.
Waddell, Amanda, Jefferson E. Vallance, Preston D. Moore, et al.. (2015). IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function. Inflammatory Bowel Diseases. 21(12). 2737–2746. 49 indexed citations
16.
Sylvester, Francisco, Catherine M. Gordon, Meena Thayu, et al.. (2013). Report of the CCFA Pediatric Bone, Growth and Muscle Health Workshop, New York City, November 11–12, 2011, With Updates. Inflammatory Bowel Diseases. 19(13). 2919–2926. 12 indexed citations
17.
Gathungu, Grace, Mi‐Ok Kim, John Ferguson, et al.. (2013). Granulocyte–Macrophage Colony-Stimulating Factor Autoantibodies. Inflammatory Bowel Diseases. 19(8). 1671–1680. 59 indexed citations
18.
Melmed, Gil, Corey A. Siegel, Brennan Spiegel, et al.. (2013). Quality Indicators for Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 19(3). 662–668. 110 indexed citations
19.
Samson, Charles M., Pamela J. Morgan, Elizabeth Williams, et al.. (2012). Improved Outcomes With Quality Improvement Interventions in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 55(6). 679–688. 32 indexed citations
20.
Han, Xiaonan, Kanji Uchida, Ingrid Jurickova, et al.. (2008). Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Murine Ileitis and Progressive Ileal Crohn's Disease. Gastroenterology. 136(4). 1261–1271.e3. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026